Dr. Manjunatha Ankathatti Munegowda Profile

Dr. Manjunatha Ankathatti Munegowda

at Theralase Technologies Inc

SPIE Involvement:

Author

Publications (2)

Proceedings Article | 14 August 2019 Presentation

A new platform technology RuVaCare, an extracorporeal anti-cancer vaccine is efficient in breaking immune barrier to target cancer cells (Conference Presentation)

Lothar Lilge, Manjunatha Ankathatti Munegowda, Arkady Mandel, Roger Dumoulin-White

Proceedings Volume 11070, 110703R (2019) https://doi.org/10.1117/12.2526627

KEYWORDS: Cancer, Tumors, Cell death, Tumor growth modeling, In vitro testing, Acquisition tracking and pointing, CRTs, Control systems

Read Abstract +

Proceedings Article | 14 August 2019 Presentation

Efficacy of ruthenium coordination complex based Rutherrin in a pre-clinical rat glioblastoma (GBM) model (Conference Presentation)

Lothar Lilge, Manjunatha Ankathatti Munegowda, Carl Fisher, Arkady Mandel

Proceedings Volume 11070, 110701F (2019) https://doi.org/10.1117/12.2525608

KEYWORDS: Ruthenium, Animal model studies, Photodynamic therapy, In vivo imaging, Brain, Brain cancer, Photons, In vitro testing, Tissues, Magnetic resonance imaging

Read Abstract +

View contact details

UPDATE YOUR PROFILE

Is this your profile? Update it now.

Sign into your SPIE.org account

Don’t have a profile and want one?

Create an account on SPIE.org

Keywords/Phrases

Search In:

Publication Years